- Home
- JILL vs TLSA Comparison
JILL vs TLSA Comparison
Compare JILL & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- TLSA
- Stock Information
- Founded
- JILL 1959
- TLSA 2013
- Country
- JILL United States
- TLSA United Kingdom
- Employees
- JILL N/A
- TLSA N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- JILL Consumer Discretionary
- TLSA Health Care
- Exchange
- JILL Nasdaq
- TLSA Nasdaq
- Market Cap
- JILL 233.1M
- TLSA 187.0M
- IPO Year
- JILL 2017
- TLSA 2000
- Fundamental
- Price
- JILL $15.09
- TLSA $2.15
- Analyst Decision
- JILL Buy
- TLSA
- Analyst Count
- JILL 3
- TLSA 0
- Target Price
- JILL $18.00
- TLSA N/A
- AVG Volume (30 Days)
- JILL 71.2K
- TLSA 445.4K
- Earning Date
- JILL 09-03-2025
- TLSA 05-06-2025
- Dividend Yield
- JILL 2.13%
- TLSA N/A
- EPS Growth
- JILL N/A
- TLSA N/A
- EPS
- JILL 2.39
- TLSA N/A
- Revenue
- JILL $601,713,000.00
- TLSA N/A
- Revenue This Year
- JILL $0.87
- TLSA N/A
- Revenue Next Year
- JILL $2.44
- TLSA N/A
- P/E Ratio
- JILL $6.31
- TLSA N/A
- Revenue Growth
- JILL N/A
- TLSA N/A
- 52 Week Low
- JILL $13.36
- TLSA $0.63
- 52 Week High
- JILL $30.40
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- JILL 31.08
- TLSA 61.78
- Support Level
- JILL $16.84
- TLSA $1.90
- Resistance Level
- JILL $16.98
- TLSA $2.09
- Average True Range (ATR)
- JILL 0.68
- TLSA 0.18
- MACD
- JILL -0.34
- TLSA 0.02
- Stochastic Oscillator
- JILL 1.07
- TLSA 75.96
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.